O6-methylguanine methyltransferase in colorectal cancers: Detection of mutations, loss of expression, and weak association with G:C>A:T transitions

Gut

Volumn 54, Issue 6, 2005, Pages 797-802

  Halford, S ^b   Rowan, A ^b   Sawyer, E ^b   Talbot, I ^a   Tomlinson, I ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CANCER CELL CULTURE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BETA CATENIN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; GENES, APC; GENES, P53; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MUTATION, MISSENSE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANS-ACTIVATORS;

EID: 19544392006     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.059535     Document Type: Article

References (32)

1. Aquilina G, Biondo R, Dogliotti E, et al. Expression of the endogenous O6-methylguanine-DNA-methyltransferase protects Chinese hamster ovary cells from spontaneous G:C to A:T transitions. Cancer Res 1992;52:6471-5.
2. Pegg AE, Dolan ME, Moschel RC. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 1995;51:167-223.
3. Zaidi NH, Pretlow TP, O'Riordan MA, et al. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis 1995;16:451-6.
4. Hampson R, Humbert O, Macpherson P, et al. Mismatch repair defects and O6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells. J Biol Chem 1997;272:28596-606.
5. Costello JF, Futscher BW, Kroes RA, et al. Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol 1994;14:6515-21.
6. Harris LC, Remack JS, Brent TP. In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcription. Biochim Biophys Acta 1994;1217:141-6.
7. von Wronski MA, Brent TP. Effect of 5-azacytidine on expression of the human DNA repair enzyme O6-methylguanine-DNA methyltransferase. Carcinogenesis 1994;15:577-82.
8. Qian X, von Wronski MA, Brent TP. Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Carcinogenesis 1995;16:1385-90.
9. Skorpen F, Krokan HE. The methylation status of the gene for O6-methylguanine-DNA methyltransferase in human: Mer+ and Mer- cells. Carcinogenesis 1995;16:1857-63.
10. Patel SA, Graunke DM, Pieper RO. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning. Mol Cell Biol 1997;17:5813-22.
11. Qian XC, Brent TP. Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res 1997;57:3672-7.
12. Kokkinakis DM, Ahmed MM, Delgado R, et al. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Cancer Res 1997;57:5360-8.
13. Watts GS, Pieper RO, Costello JF, et al. Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 1997;17:5612-19.
14. Xiao W, Samson L. In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc Natl Acad Sci U S A 1993;90:2117-21.
15. Jackson PE, Hall CN, O'Connor PJ, et al. Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC->AT transition in the K-ras oncogene. Carcinogenesis 1997;18:1299-302.
16. Esteller M, Hamilton SR, Burger PC, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-7.
17. Esteller M, Fraga MF, Guo M, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001;10:3001-7.
18. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001;61:4689-92.
19. Whitehall VL, Walsh MD, Young J, et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001;61:827-30.
20. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60:2368-71.
21. Laiho P, Launonen V, Lahermo P, et al. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 2002;62:1166-70.
22. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
23. Yamashita K, Dai T, Dai Y, et al. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 2003;4:121-31.
24. Rowan AJ, Lamlum H, Ilyas M, et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A 2000;97:3352-7.
25. Halford SE, Sawyer EJ, Lambros MB, et al. MSI-low, a real phenomenon which varies in frequency among cancer types. J Pathol 2003;201:389-94.
26. Sieber OM, Heinimann K, Gorman P, et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci U S A 2002;99:16910-15.
27. Xu-Welliver M, Kanugula S, Loktionova NA, et al. Conserved residue lysine 165 is essential for the ability of O6-alkylguanine-DNA alkyltransferase to react with O6-benzylguanine. Biochem J 2000;347(Pt 2):527-34.
28. Xu-Welliver M, Pegg AE. Point mutations at multiple sites including highly conserved amino acids maintain activity, but render O6-alkylguanine-DNA alkyltransferase insensitive to O6-benzylguanine. Biochem J 2000;347(Pt2):519- 26.
29. Lind GE, Thorstensen L, Lovig T, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004;3:28.
30. Chueh LL, Nakamura T, Nakatsu Y, et al. Specific amino acid sequences required for O6-methylguanine-DNA methyltransferase activity: analyses of three residues at or near the methyl acceptor site. Carcinogenesis 1992;13:837-43.
31. Branch P, Hampson R, Karran P. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res 1995;55:2304-9.
32. Sandercock LE, Kwok MC, Luchman HA, et al. Mutational-reporter transgenes rescued from mice lacking either Mgmt, or both Mgmt and Msh6 suggest that O6-alkylguanine-induced miscoding does not contribute to the spontaneous mutational spectrum. Oncogene 2004;23:5931-40.